TārāMD

BHRT (Bioidentical Hormone Replacement Therapy) is not automatically safe; it carries risks similar to traditional hormone therapy, including weight gain, mood swings, and an increased risk of blood clots, though doctors distinguish between FDA-approved and compounded versions [1][5]. What doctors say about bioidentical hormones: FDA-Approved vs. Compounded: Doctors emphasize that FDA-approved bioidentical hormones (like estradiol and micronized progesterone) are tested for safety and meet strict standards, whereas compounded bioidentical hormones are custom-mixed by pharmacies without FDA oversight, leading to inconsistent potency and quality [3][5][7]. Safety Claims Debunked: Major medical organizations, including the Mayo Clinic, Cleveland Clinic, and the North American Menopause Society, state that there is no scientific evidence that compounded bioidentical hormones are safer or more effective than traditional hormone therapy [5][7][8]. Potential Benefits: Some research suggests that FDA-approved bioidentical hormones may have a slightly lower risk of blood clots and less negative impact on blood lipids compared to synthetic progestins, and some doctors (like those at TārāMD) consider them a "bit safer" option for customized peri/menopause protocols [2][3][9]. Weighing Risks: Doctors agree that while BHRT is a promising option for managing menopausal symptoms, patients must weigh the benefits against risks such as blood clots, stroke, and potential increased risks of breast cancer with long-term use [1][5]. Recommendation: If considering BHRT, choose FDA-approved formulations and work with a healthcare provider for personalized care and proactive monitoring to ensure safety, rather than relying on unregulated compounded products [1][5].

Mentioned in position 1 of 1